Retrieve available abstracts of 197 articles: HTML format
Single Articles
July 2025
LIU H, Fang Y, Cheng W Traumatic interventricular septal dissection in a bicuspid aortic valve patient:
a rare extension into the left ventricle.
Eur Heart J. 2025 Jul 4:ehaf499. doi: 10.1093. PubMed
BLITZER D, Meinrenken CJ, Apelgren NB, Chavez XS, et al Carbon emission analysis of aortic valve replacement: the environmental footprint
of transcatheter vs. surgical procedures.
Eur Heart J. 2025 Jul 2:ehaf379. doi: 10.1093. PubMedAbstract available
June 2025
YANG WL, Hu BY Giant ascending aortic aneurysm in a 6-year-old boy with LOX gene mutation
associated with familial thoracic aortic aneurysm type 10.
Eur Heart J. 2025 Jun 24:ehaf402. doi: 10.1093. PubMed
CREA F Focus on juvenile hypertension, deep learning-qualified body composition for risk
stratification, infective endocarditis, and mixed valvular heart disease.
Eur Heart J. 2025;46:2249-2252. PubMed
COMPAGNONE M, Windecker S, Dall'Ara G, Galvani M, et al Great debate: Transcatheter aortic valve implantation should also be performed in
non-surgical centres.
Eur Heart J. 2025 Jun 5:ehaf363. doi: 10.1093. PubMed
NITSCHE C, Dobner S, Rosenblum HR, Patel KP, et al Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve
replacement for severe stenosis.
Eur Heart J. 2025 Jun 2:ehaf362. doi: 10.1093. PubMedAbstract available
May 2025
BASU J, Nikoletou D, Miles C, MacLachlan H, et al High intensity exercise programme in patients with hypertrophic cardiomyopathy: a
randomized trial.
Eur Heart J. 2025;46:1803-1815. PubMedAbstract available
ISHIKAWA E, Kageyama S Acquired von Willebrand syndrome caused by paravalvular prosthetic mitral
regurgitation.
Eur Heart J. 2025 May 13:ehaf334. doi: 10.1093. PubMed
BARBANTI M, Costa G, Windecker S, Maisano F, et al Bicuspid aortic valve disease: advancements and challenges of transcatheter
aortic valve implantation.
Eur Heart J. 2025 May 9:ehaf307. doi: 10.1093. PubMedAbstract available
PEDICINO D, Liuzzo G Weekly Journal Scan: does dapagliflozin expand the therapeutic options after
transcatheter aortic valve implantation?
Eur Heart J. 2025 May 6:ehaf309. doi: 10.1093. PubMed
LIN S, Zhang H, Li Z Quadricuspid aortic valve with partial left coronary sinus isolation.
Eur Heart J. 2025 May 2:ehaf252. doi: 10.1093. PubMed
April 2025
VAN KAMPEN A, Levine RA, Borger MA Is mitral annular disjunction the cause of arrhythmogenic mitral valve prolapse?
Eur Heart J. 2025 Apr 24:ehaf264. doi: 10.1093. PubMed
COISNE A, Lancellotti P, Cote N, Ternacle J, et al Blood biomarkers in left-sided valvular heart disease.
Eur Heart J. 2025 Apr 22:ehaf232. doi: 10.1093. PubMedAbstract available
LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al Mitral annular disjunction and mitral valve prolapse: long-term risk of
ventricular arrhythmias after surgery.
Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093. PubMedAbstract available
ZITO F, Rhellab R, de Keijzer AR Patient-prosthesis mismatch after aortic valve replacement: one size does not fit
all.
Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093. PubMed
PATEL KP, Baumbach A Clinical implications of sex-related differences in severe aortic stenosis.
Eur Heart J. 2025 Apr 8:ehaf199. doi: 10.1093. PubMed
TCHETCHE D, Pibarot P, Bax JJ, Bonaros N, et al Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
Eur Heart J. 2025 Apr 2:ehaf133. doi: 10.1093. PubMedAbstract available
March 2025
LONG A, Finer J, Hartman H, Hartzel D, et al Deep learning for echocardiographic assessment and risk stratification of aortic,
mitral, and tricuspid regurgitation: the DELINEATE-Regurgitation study.
Eur Heart J. 2025 Mar 29:ehaf248. doi: 10.1093. PubMedAbstract available
CHEN M, Michel J, Kasel AM 26 mm SAPIEN fractured 23 mm SAPIEN and surgical prosthesis: a transcatheter
aortic valve-in-valve-in-valve implantation.
Eur Heart J. 2025 Mar 29:ehaf173. doi: 10.1093. PubMed
INDOLFI C, Esposito G, Luscher TF TAVI or TAVR: it is time to use a single standardized acronym for percutaneous
aortic valve implantation.
Eur Heart J. 2025 Mar 13:ehaf048. doi: 10.1093. PubMed
February 2025
MOCUMBI A European Society of Cardiology guidelines for the management of valvular heart
disease: should we apply these to rheumatic heart disease?
Eur Heart J. 2025 Feb 28:ehae641. doi: 10.1093. PubMed
UNGER P, Galloo X, Pibarot P Mixed valvular heart disease: diagnosis and management.
Eur Heart J. 2025 Feb 27:ehaf116. doi: 10.1093. PubMedAbstract available
BAUMGARTNER H, Iung B, Messika-Zeitoun D The Year in Cardiovascular Medicine 2024: the top 10 papers in valvular heart
disease.
Eur Heart J. 2025 Feb 27:ehaf071. doi: 10.1093. PubMed
PEDICINO D, Vergallo R Weekly Journal Scan: is transcatheter replacement therapy for tricuspid
regurgitation ready for prime time?
Eur Heart J. 2025 Feb 19:ehaf060. doi: 10.1093. PubMed
SPRINGHETTI P, Abdoun K, Dumont E, Dagenais F, et al Sex-related differences in prosthesis-patient mismatch after surgical aortic
valve replacement and long-term outcomes.
Eur Heart J. 2025 Feb 18:ehaf076. doi: 10.1093. PubMedAbstract available
DE PAULIS R, Chirichilli I, de Kerchove L, Della Corte A, et al Current status of aortic valve repair surgery.
Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093. PubMedAbstract available
VERGALLO R, Pedicino D Weekly Journal Scan: transcatheter vs. surgical treatment of combined severe
aortic valve stenosis and obstructive coronary artery disease.
Eur Heart J. 2025 Feb 14:ehaf023. doi: 10.1093. PubMed
CREA F Focus on aortic stenosis prevention and mitral regurgitation diagnosis.
Eur Heart J. 2025;46:595-597. PubMed
ABDELHAMID M, Abdel Meged AM, Prendergast B, Calvo-Iglesias FE, et al Baseline characteristics and outcomes of rheumatic mitral valve disease: the
EURObservational Research Programme Valvular Heart Disease II Survey.
Eur Heart J. 2025 Feb 11:ehaf050. doi: 10.1093. PubMedAbstract available
ANGELLOTTI D, Praz F, Windecker S Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge
repair: a complex interplay.
Eur Heart J. 2025 Feb 10:ehaf044. doi: 10.1093. PubMed
January 2025
MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge
repair.
Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093. PubMedAbstract available
LURZ P, Zancanaro E, Kresoja KP Personalized management of tricuspid valve regurgitation.
Eur Heart J. 2025 Jan 11:ehae733. doi: 10.1093. PubMed
AARTS HM, Voskuil M, Delewi R Coronary revascularization in randomized clinical trials comparing transcatheter
and surgical aortic valve replacement: is it time to bridge the gap?
Eur Heart J. 2025 Jan 9:ehae762. doi: 10.1093. PubMed
December 2024
ANG DTY, Lindsay MM Plugging the gap: vascular access closure after transfemoral transcatheter aortic
valve implantation.
Eur Heart J. 2024 Dec 23:ehae876. doi: 10.1093. PubMed
GARCIA-PAVIA P, Oreziak A, Masri A, Barriales-Villa R, et al Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy.
Eur Heart J. 2024;45:5071-5083. PubMedAbstract available
VERGALLO R, Pedicino D Weekly Journal Scan: Pushing the boundaries of transcatheter aortic valve
implantation in asymptomatic patients with severe aortic stenosis.
Eur Heart J. 2024 Dec 11:ehae839. doi: 10.1093. PubMed
SUN Y, Wang Z, Qian Y What's the relationship between secondary mitral regurgitation and secondary
tricuspid regurgitation in atrial fibrillation patients and how to treat them?
Eur Heart J. 2024 Dec 4:ehae815. doi: 10.1093. PubMed
NASER JA, Siontis KC, Nkomo VT The steps towards understanding tricuspid regurgitation: one 'careful' step at a
time and many more 'careful' steps needed.
Eur Heart J. 2024 Dec 4:ehae816. doi: 10.1093. PubMed
HALLE M, Wernhart S, Krane M Exercise in primary, secondary and tertiary prevention of aortic stenosis.
Eur Heart J. 2024 Dec 4:ehae627. doi: 10.1093. PubMed
BLASER MC, Back M, Luscher TF, Aikawa E, et al Calcific aortic stenosis: omics-based target discovery and therapy development.
Eur Heart J. 2024 Dec 4:ehae829. doi: 10.1093. PubMedAbstract available
November 2024
GARG P, Pavon AG, Penicka M, Uretsky S, et al Cardiovascular magnetic resonance imaging in mitral valve disease.
Eur Heart J. 2024 Nov 20:ehae801. doi: 10.1093. PubMedAbstract available
LI Z, Xiang D, Hu K Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe
mitral regurgitation in Marfan syndrome after Bentall procedure.
Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093. PubMed
VERGALLO R, Pedicino D Weekly Journal Scan: Should we treat obstructive coronary artery disease in
patients undergoing transcatheter aortic valve implantation?
Eur Heart J. 2024 Nov 12:ehae761. doi: 10.1093. PubMed
COATS CJ, Masri A, Barriales-Villa R, Abraham TP, et al Cardiac biomarkers and effects of aficamten in obstructive hypertrophic
cardiomyopathy: the SEQUOIA-HCM trial.
Eur Heart J. 2024;45:4464-4478. PubMedAbstract available
CREA F Evolving therapeutic approaches to aortic stenosis, tricuspid regurgitation,
hypertrophic cardiomyopathy, and acute heart failure.
Eur Heart J. 2024;45:4451-4455. PubMed
October 2024
RHEUDE T, Ruge H, Altaner N, Pellegrini C, et al Comparison of strategies for vascular ACCESS closure after transcatheter aortic
valve implantation: the ACCESS-TAVI randomized trial.
Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093. PubMedAbstract available
PEDICINO D, Vergallo R Weekly Journal Scan: RESHAPing potential treatment indications for functional
mitral regurgitation in heart failure.
Eur Heart J. 2024 Oct 29:ehae727. doi: 10.1093. PubMed
PEDICINO D, Vergallo R Weekly Journal Scan: is MATTERHORN a game changer for secondary mitral
regurgitation? Still climbing.
Eur Heart J. 2024 Oct 11:ehae650. doi: 10.1093. PubMed
DE CATERINA R, Ten Cate H, Pengo V Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a
tale of bridging vs. no bridging.
Eur Heart J. 2024 Oct 8:ehae615. doi: 10.1093. PubMed
LANCELLOTTI P, Go YY, Vannan MA Unveiling sex differences in valvular disease care and outcomes.
Eur Heart J. 2024;45:3834-3836. PubMed
September 2024
TALHA KM, Metra M, Butler J Heart failure with preserved ejection fraction: underdiagnosed and undertreated
in patients with tricuspid regurgitation.
Eur Heart J. 2024 Sep 9:ehae544. doi: 10.1093. PubMed
SCHOFER N, Blankenberg S Transfemoral or surgical aortic valve replacement in young low-risk patients with
tricuspid and bicuspid aortic valve stenosis.
Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093. PubMed
SATO M, Yoshijima N, Yashima F Sinus sequestration due to transcatheter heart valve endothelialization after
transcatheter aortic valve replacement.
Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093. PubMed
PRENDERGAST BD, Patterson T, Redwood S Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful
prevention.
Eur Heart J. 2024;45:3042-3044. PubMed
ACKERMANN P, Abdel-Wahab M, Noack T Macroscopic findings of severe structural valve deterioration of a transcatheter
aortic bioprosthesis.
Eur Heart J. 2024;45:3092. PubMed
MARTINSSON A, Jeppsson A Invited editorial on "Outcome of aortic valve replacement versus conservative
treatment in asymptomatic patients with severe aortic stenosis - Five years
follow-up of the AVATAR randomized controlled trial" by Banovic et al.
Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093. PubMed
BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al Aortic valve replacement versus conservative treatment in asymptomatic severe
aortic stenosis: long-term follow-up of the AVATAR trial.
Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093. PubMedAbstract available
August 2024
BONAROS N, Gollmann-Tepekoylu C, Grimm M Tricuspid valve trilogy: between risks and timing for surgery.
Eur Heart J. 2024 Aug 30:ehae562. doi: 10.1093. PubMed
DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al Benefit of isolated surgical valve repair or replacement for functional tricuspid
regurgitation and long-term outcomes stratified by the TRI-SCORE.
Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093. PubMedAbstract available
MASCHERBAUER J, Kammerlander A, Nitsche C, Bax J, et al Sex-related differences in severe native valvular heart disease: the ESC-EORP
Valvular Heart Disease II survey.
Eur Heart J. 2024 Aug 30:ehae523. doi: 10.1093. PubMedAbstract available
NOTENBOOM ML, de Keijzer AR, Veen KM, Gokalp A, et al Sex-related differences in the clinical course of aortic root and ascending
aortic aneurysms: the DisSEXion Study.
Eur Heart J. 2024 Aug 26:ehae525. doi: 10.1093. PubMedAbstract available
BAI L, Feng Y, Chen M A very rare complication of transcatheter aortic valve replacement.
Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093. PubMed
MACH F, Miteva K Window of opportunity for developing effective medical intervention for calcific
aortic valve disease.
Eur Heart J. 2024 Aug 12:ehae426. doi: 10.1093. PubMed
LOPES LR, Ho CY, Elliott PM Genetics of hypertrophic cardiomyopathy: established and emerging implications
for clinical practice.
Eur Heart J. 2024;45:2727-2734. PubMedAbstract available
July 2024
WANG J, Hu P, Ma XJ Mechanical mitral valve obstruction: gone with the wind.
Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093. PubMed
GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S Time is relative, also when comparing transcatheter edge-to-edge repair to mitral
valve surgery.
Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093. PubMed
BERNARD A, Deharo P, Fauchier L Time matters when considering treatment for patients with mitral regurgitation.
Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093. PubMed
CREA F A new classification of iron-deficient heart failure, sex-related differences in
the management of atrial fibrillation and mitral regurgitation, and an update on
the genetics of Brugada syndrome.
Eur Heart J. 2024;45:2267-2270. PubMed
ARSENOS P, Tsioufis K, Gatzoulis KA Programmed ventricular stimulation for risk stratification in hypertrophic
cardiomyopathy patients.
Eur Heart J. 2024;45:2341-2342. PubMed
HUANG Y, Wang C, Zhou T, Xie F, et al Lumican promotes calcific aortic valve disease through H3 histone lactylation.
Eur Heart J. 2024 Jul 8:ehae407. doi: 10.1093. PubMedAbstract available
MURARU D, Badano LP Impact of new-onset atrial fibrillation on the incidence of tricuspid
regurgitation: a call to attention.
Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093. PubMed
JAHANYAR J, de Kerchove L, El Khoury G Forme fruste unicuspid aortic valves.
Eur Heart J. 2024 Jul 3:ehae432. doi: 10.1093. PubMed
THYREGOD HGH, De Backer O, Sondergaard L A notion of bioprosthetic aortic valve durability.
Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093. PubMed
LI Z, Cheng S, Guo B, Ding L, et al Wearable device-measured moderate to vigorous physical activity and risk of
degenerative aortic valve stenosis.
Eur Heart J. 2024 Jul 2:ehae406. doi: 10.1093. PubMedAbstract available
BEKKI M, Tahara N, Fukumoto Y Primary cardiac lymphoma causing coronary artery compression and massive
tricuspid regurgitation.
Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093. PubMed
DIMITRIADIS K, Pyrpyris N, Tsioufis K Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is
there still a question to be answered?
Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093. PubMed
NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial
fibrillation vs. sinus rhythm.
Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093. PubMedAbstract available
June 2024
HAHN RT Sex-related differences in degenerative mitral regurgitation: a call to action.
Eur Heart J. 2024 Jun 13:ehae360. doi: 10.1093. PubMed
ZHUANG Y, Wang W, Lu F Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral
cervical approach.
Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093. PubMed
CREA F Optimizing the treatment of severe aortic stenosis.
Eur Heart J. 2024;45:1861-1865. PubMed
VERGALLO R, Pedicino D Weekly Journal Scan: transcatheter aortic valve implantation in patients with
small aortic annulus.
Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093. PubMed
May 2024
ELTCHANINOFF H, Durand E Transfemoral aortic valve implantation and concomitant CAD: the jury is out.
Eur Heart J. 2024 May 31:ehae141. doi: 10.1093. PubMed
WANG J, Chen X, Zhao S Detect and define ventricular arrhythmia substrates in hypertrophic
cardiomyopathy.
Eur Heart J. 2024 May 31:ehae312. doi: 10.1093. PubMed
Correction to: Severe aortic stenosis: secular trends of incidence and outcomes.
Eur Heart J. 2024 May 27:ehae144. doi: 10.1093. PubMed
AVIERINOS JF, Tribouilloy C, Bursi F, Grigioni F, et al Degenerative mitral regurgitation due to flail leaflet: sex-related differences
in presentation, management, and outcomes.
Eur Heart J. 2024 May 16:ehae265. doi: 10.1093. PubMedAbstract available
DVIR D, Tchetche D, Leon MB, Genereux P, et al Leaflet modification before transcatheter aortic valve implantation in patients
at risk for coronary obstruction: the ShortCut study.
Eur Heart J. 2024 May 15:ehae303. doi: 10.1093. PubMedAbstract available
JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic
Stenosis: The NOTION-2 Trial.
Eur Heart J. 2024 May 15:ehae331. doi: 10.1093. PubMedAbstract available
SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
Eur Heart J. 2024 May 14:ehae224. doi: 10.1093. PubMedAbstract available
ZEPPENFELD K, de Riva M Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open
but don't jump at every shadow.
Eur Heart J. 2024 May 14:ehae246. doi: 10.1093. PubMed
April 2024
PIBAROT P Transcatheter aortic valve replacement: benchmarking practices to optimize
quality and outcomes.
Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093. PubMed
PIERONI M, Namdar M, Olivotto I, Desnick RJ, et al Anderson-Fabry disease management: role of the cardiologist.
Eur Heart J. 2024;45:1395-1409. PubMedAbstract available
KASKI JP, Norrish G, Gimeno Blanes JR, Charron P, et al Cardiomyopathies in children and adolescents: aetiology, management, and outcomes
in the European Society of Cardiology EURObservational Research Programme
Cardiomyopathy and Myocarditis Registry.
Eur Heart J. 2024;45:1443-1454. PubMedAbstract available
TAHARA N, Fukumoto Y, Tayama E Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission
tomography/computed tomography to assess left ventricular workload in obstructive
hypertrophic cardiomyopathy.
Eur Heart J. 2024;45:1488. PubMed
BLEIZIFFER S Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term
data, yet a long way to go.
Eur Heart J. 2024;45:1125-1126. PubMed
March 2024
FRANK D, Durand E, Lauck S, Muir DF, et al A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK
study.
Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093. PubMedAbstract available
Correction to: Tricuspid valve disease and cardiac implantable electronic
devices.
Eur Heart J. 2024 Mar 29:ehae221. doi: 10.1093. PubMed
BAKAR SN, Ong G, Fam NP LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid
flail after lead extraction.
Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093. PubMed
Correction to: Healthcare resource utilisation and safety outcomes in patients
undergoing transcatheter mitral valve repair - A nationwide analysis.
Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093. PubMed
CREA F Mitral, aortic, and tricuspid valve disease: new light shed on mechanisms, risk
stratification, and treatment optimization.
Eur Heart J. 2024;45:857-860. PubMed
BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al Great debate: symptomatic moderate aortic stenosis should undergo intervention.
Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093. PubMed
MARTINSSON A, Rasalingam R, Jeppsson A Stable incidence and outcomes for patients with incident aortic stenosis: how can
we translate excellent trial data into improved clinical outcomes in the
population?
Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093. PubMed
SUDO K, Nakamura K, Sato A Usefulness of endomyocardial biopsy using three-dimensional delivery system for
the diagnosis of cardiac amyloidosis with complete atrioventricular block after
transcatheter aortic valve implantation.
Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093. PubMed
MURARU D, Badano LP, Hahn RT, Lang RM, et al Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis,
and treatment.
Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093. PubMedAbstract available
MEHILLI J Shortening in-hospital stay after transcatheter aortic valve implantation: a deja
vu in percutaneous interventions.
Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093. PubMed
DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al Reducing length of stay after transfemoral transcatheter aortic valve
implantation: the FAST-TAVI II trial.
Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093. PubMedAbstract available
MCGREGOR M, Bews H, Jassal DS Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place.
Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093. PubMed
MAISANO F, Hahn R, Sorajja P, Praz F, et al Transcatheter treatment of the tricuspid valve: current status and perspectives.
Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093. PubMedAbstract available
February 2024
WU J, Zafar MA, Elefteriades JA Decision-making in aortic disease.
Eur Heart J. 2024;45:633-634. PubMed
MESSIKA-ZEITOUN D, Iung B, Baumgartner H The year in cardiovascular medicine 2023: the top 10 papers in valvular heart
disease.
Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093. PubMed
LURZ P, Kresoja KP Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093. PubMed
LUDWIG S, Granada JF Transcatheter mitral valve replacement at an inflection point: lessons learned
and the path forward.
Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093. PubMed
THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al Transcatheter or surgical aortic valve implantation: 10-year outcomes of the
NOTION trial.
Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093. PubMedAbstract available
CREA F The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and
drug toxicity.
Eur Heart J. 2024;45:317-320. PubMed
January 2024
THORNTON GD, Vassiliou VS, Musa TA, Aziminia N, et al Myocardial Scar and Remodelling Predict Long-Term Mortality in Severe Aortic
Stenosis Beyond 10 Years.
Eur Heart J. 2024 Jan 25:ehae067. doi: 10.1093. PubMed
PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al Impact of untreated chronic obstructive coronary artery disease on outcomes after
transcatheter aortic valve replacement.
Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093. PubMedAbstract available
DEHARO P, Obadia JF, Guerin P, Cuisset T, et al Mitral transcatheter edge to edge repair versus isolated mitral surgery for
severe mitral regurgitation: A French nationwide study.
Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093. PubMedAbstract available
HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al Artificial intelligence-derived risk score for mortality in secondary mitral
regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk
score.
Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093. PubMedAbstract available
NAKAMURA K, Taniguchi T, Furukawa Y Haemolytic anaemia after transcatheter aortic valve replacement.
Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093. PubMed
LI Z, Zhang H, Lin S Functionally bicuspid aortic valve leads to myocardial ischaemia.
Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093. PubMed
LONG X, Deng S, Liu W, Bu J, et al Transcoronary radiofrequency ablation for obstructive hypertrophic
cardiomyopathy: a feasibility study.
Eur Heart J. 2024;45:233-235. PubMed
HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international
registry.
Eur Heart J. 2024;45:198-210. PubMedAbstract available
BENFARI G, Essayagh B, Michelena HI, Ye Z, et al Severe aortic stenosis: secular trends of incidence and outcomes.
Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093. PubMedAbstract available
KADDOURA R, Al-Hijji M The evolution of transcatheter valvular interventions: current evidence.
Eur Heart J. 2024;45:10-14. PubMed
December 2023
ALLOUBA M, Walsh R, Afify A, Hosny M, et al Ethnicity, consanguinity, and genetic architecture of hypertrophic
cardiomyopathy.
Eur Heart J. 2023;44:5146-5158. PubMedAbstract available
INGLES J, MacArthur DG The moral and practical urgency of increasing diversity in genomics.
Eur Heart J. 2023;44:5157-5159. PubMed
ANDREAS M, Burri H, Praz F, Soliman O, et al Tricuspid valve disease and cardiac implantable electronic devices.
Eur Heart J. 2023 Dec 14:ehad783. doi: 10.1093. PubMedAbstract available
PIRIOU PG, Plessis J, Guerin P Transcatheter aortic valve replacement in patients with cardiogenic shock: safe
and effective, but the most critical patients require further investigations.
Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093. PubMed
GRANI C Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic
cardiomyopathy.
Eur Heart J. 2023;44:4793-4795. PubMed
WANG J, Yang S, Ma X, Zhao K, et al Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves
risk stratification based on current guidelines.
Eur Heart J. 2023;44:4781-4792. PubMedAbstract available
November 2023
VERGALLO R, Volpe M Breaking down barriers to transcatheter aortic-valve implantation in low surgical
risk patients.
Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093. PubMed
LU ZN, Yang Y, Song G A patient-tailored clipping strategy of transcatheter edge-to-edge repair as
salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet
flails.
Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093. PubMed
BRAUNWALD E, Saberi S, Abraham TP, Elliott PM, et al Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic
cardiomyopathy.
Eur Heart J. 2023;44:4622-4633. PubMedAbstract available
TOMII D, Praz F, Windecker S Guideline directed medical therapy in patients with heart failure undergoing
transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093. PubMed
CREA F Hot topics in valvular heart disease: tricuspid regurgitation, bicuspid aortic
valve, artificial intelligence for aortic stenosis, and aortic aneurysm.
Eur Heart J. 2023;44:4493-4496. PubMed
PATEL KP, Baumbach A Timing treatment for tricuspid regurgitation.
Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093. PubMed
WERT L, Falk V, Potapov EV Severe aortic regurgitation after short-term treatment with microaxial left
ventricular assist device in the transaxillary approach.
Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093. PubMed
IDHREES M, Kumar A, Velayudhan B 'Paravalvular leak' after Bentall's procedure, yet not a paravalvular leak.
Eur Heart J. 2023;44:4392. PubMed
KODALI S, Hahn RT, Makkar R, Makar M, et al Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND
study.
Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093. PubMedAbstract available
October 2023
HARARI E, Landes U Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple
aetiologies and no panacea.
Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093. PubMed
KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al Intravascular ultrasound for actual bioprosthetic heart valve expansion during
transcatheter bicuspid aortic valve replacement.
Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093. PubMed
DE BACKER J, Prakash SK Refining the course: long-term outcome in patients with bicuspid aortic valve.
Eur Heart J. 2023 Oct 4:ehad621. doi: 10.1093. PubMed
FARJAT-PASOS JI, Dumont E, Paradis JM Optimizing transcatheter mitral valve replacement with direct, continuous
transvalvular haemodynamic evaluation: first-in-man.
Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093. PubMed
HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al Tricuspid Valve Academic Research Consortium Definitions for Tricuspid
Regurgitation and Trial Endpoints.
Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093. PubMedAbstract available
WEISSLER-SNIR A, Rakowski H, Meyer M Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the
heart rate restriction?
Eur Heart J. 2023;44:3655-3657. PubMed
DEVRIES JH, Irs A, Hillege HL The European Medicines Agency assessment of mavacamten as treatment of
symptomatic obstructive hypertrophic cardiomyopathy in adult patients.
Eur Heart J. 2023;44:3492-3494. PubMed
September 2023
CHHABRA ST, Takkar A, Arya RC An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic
valve implantation'.
Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093. PubMed
BEYGUI F, Guillemot V, Saloux E Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093. PubMed
MOORE JP, Aboulhosn JA, Khairy P Electrophysiology testing before transcatheter pulmonary valve replacement in
patients with repaired tetralogy of Fallot.
Eur Heart J. 2023;44:3228-3230. PubMed
CREA F TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in
patients with Heyde syndrome?
Eur Heart J. 2023;44:3105-3109. PubMed
FENG S, Wu F, Pan X Computational fluid dynamics as a novel method to predict haemodynamic changes
and guide transcatheter edge-to-edge repair.
Eur Heart J. 2023;44:3199. PubMed
August 2023
VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair:
The STS/ACC Transcatheter Valve Therapy Registry.
Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093. PubMedAbstract available
DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al TRI-SCORE and benefit of intervention in patients with severe tricuspid
regurgitation.
Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093. PubMedAbstract available
YANG LT, Ye Z, Wajih Ullah M, Maleszewski JJ, et al Bicuspid aortic valve: long-term morbidity and mortality.
Eur Heart J. 2023 Aug 23:ehad477. doi: 10.1093. PubMedAbstract available
HOLSTE G, Oikonomou EK, Mortazavi BJ, Coppi A, et al Severe aortic stenosis detection by deep learning applied to echocardiography.
Eur Heart J. 2023 Aug 23:ehad456. doi: 10.1093. PubMedAbstract available
VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al End-stage heart failure in congenitally corrected transposition of the great
arteries: a multicentre study.
Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093. PubMedAbstract available
PRENDERGAST BD, Patterson T, Redwood S Transcatheter aortic valve implantation in patients with severe aortic stenosis
and cardiogenic shock: an important step forward.
Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093. PubMed
ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology,
risk stratification, and management.
Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093. PubMedAbstract available
AL ZAIDI M, Nickenig G, Zimmer S Emergency transcatheter aortic valve replacement in a 35-year-old patient with
unicuspid aortic valve disease and cardiogenic shock.
Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093. PubMed
EIROS R, Gallego-Delgado M, Villacorta E Unravelling an hypertrophic myocardiopathy.
Eur Heart J. 2023;44:2788. PubMed
July 2023
IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al Great debate: all patients with asymptomatic severe aortic stenosis need valve
replacement.
Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093. PubMed
WALDSCHMIDT L, Seiffert M Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?
Eur Heart J. 2023 Jul 5:ehad277. doi: 10.1093. PubMed
GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093. PubMedAbstract available
LORENZATTI D, Pina P, Slipczuk L Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis
dysfunction: the thin line between hypo attenuated leaflet thickening and
clinical valve thrombosis.
Eur Heart J. 2023;44:2350. PubMed
June 2023
NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093. PubMedAbstract available
GOEL K, Shah P, Jones BM, Korngold E, et al Outcomes of transcatheter aortic valve replacement in patients with cardiogenic
shock.
Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093. PubMedAbstract available
Corrigendum to: MitraClip single-leaflet detachment and consequent migration in
atrial functional mitral regurgitation.
Eur Heart J. 2023 Jun 21:ehad407. doi: 10.1093. PubMed
TAKANO R, Tsuji A, Ogo T A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia
after palliative surgery.
Eur Heart J. 2023 Jun 17:ehad402. doi: 10.1093. PubMed
PEDICINO D, Vergallo R Long-lasting effects of transcatheter repair of secondary mitral regurgitation:
the latest lesson from COAPT trial.
Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093. PubMed
BRAY JJH, Freer R, Pitcher A, Kharbanda R, et al Family screening for bicuspid aortic valve and aortic dilatation: a
meta-analysis.
Eur Heart J. 2023 Jun 8:ehad320. doi: 10.1093. PubMedAbstract available
EVANGELISTA A, Michelena HI Family screening for bicuspid aortic valve: indicated, but easy to implement?
Eur Heart J. 2023 Jun 8:ehad057. doi: 10.1093. PubMed
CREA F Understanding aortic stenosis: advances in the identification of actionable
pharmacological targets.
Eur Heart J. 2023;44:1847-1850. PubMed
May 2023
LORENZINI M, Elliott PM Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
Eur Heart J. 2023;44:1519-1521. PubMed
JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al Pregnancy outcomes in women with heart disease: the Madras Medical College
Pregnancy And Cardiac (M-PAC) Registry from India.
Eur Heart J. 2023;44:1530-1540. PubMedAbstract available
April 2023
BUTCHER SC, Essayagh B, Enriquez-Sarano M Rescue surgery for degenerative mitral regurgitation should be recognized for
what it is: indispensable but imperfect.
Eur Heart J. 2023 Apr 28:ehad242. doi: 10.1093. PubMed
DANDEL M Degenerative mitral regurgitation: improving clinical decision-making and risk
stratification before valve surgery or trans-catheter repair.
Eur Heart J. 2023 Apr 28:ehad216. doi: 10.1093. PubMed
LI Y, He Q, Xie M A rare case of papillary muscle rupture caused by percutaneous balloon mitral
valvuloplasty.
Eur Heart J. 2023 Apr 26:ehad254. doi: 10.1093. PubMed
LEE J, Kim JS, Shim CY MitraClip single-leaflet detachment and consequent migration in atrial functional
mitral regurgitation.
Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093. PubMed
PEDICINO D, Vergallo R Transcatheter repair for severe tricuspid regurgitation: are we going in the
right direction?
Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093. PubMed
ORRINGER CE C-reactive protein in people with high lipoprotein a: a partner in crime or an
innocent bystander?
Eur Heart J. 2023;44:1461-1463. PubMed
THERIAULT S, Mathieu P, Bosse Y The journey towards identification of actionable molecular pathways in calcific
aortic valve stenosis.
Eur Heart J. 2023 Apr 12:ehad134. doi: 10.1093. PubMed
CHEN HY, Dina C, Small AM, Shaffer CM, et al Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a
genome-wide study.
Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093. PubMedAbstract available
SEQUEIRA V, Batzner A, Maack C Targeting mitochondria in hypertrophic cardiomyopathy.
Eur Heart J. 2023;44:1186-1188. PubMed
NOLLET EE, Duursma I, Rozenbaum A, Eggelbusch M, et al Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to
cardiomyocyte architecture disruption and corrected by improving NADH-driven
mitochondrial respiration.
Eur Heart J. 2023;44:1170-1185. PubMedAbstract available
March 2023
KAGASE A, Yamamoto M, Tokuda T Successful bailout clipping for rare complication of anterior mitral leaflet
dissection during transcatheter edge-to-edge mitral valve repair.
Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093. PubMed
XIE Z, Zhu H A rare case of mitral regurgitation caused by primary aldosteronism.
Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093. PubMed
CHEN YH, Chang HH, Leu HB Redo-transcatheter aortic valve implantation in a patient at high risk of
coronary obstruction due to sinus sequestration.
Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093. PubMed
MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al Mosaic loss of Y chromosome in monocytes is associated with lower survival after
transcatheter aortic valve replacement.
Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093. PubMedAbstract available
CHORIN E, Topilsky Y The synergy between tricuspid regurgitation and machine learning.
Eur Heart J. 2023 Mar 17:ehad140. doi: 10.1093. PubMed
RAO VN, Giczewska A, Chiswell K, Felker GM, et al Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093. PubMedAbstract available
MESSIKA-ZEITOUN D, Baumgartner H, Burwash IG, Vahanian A, et al Unmet needs in valvular heart disease.
Eur Heart J. 2023 Mar 16:ehad121. doi: 10.1093. PubMedAbstract available
CHUNG CJ, Otto CM Prevention and management of paravalvular regurgitation after transcatheter
aortic valve implantation.
Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093. PubMed
LANDES U, Hochstadt A, Manevich L, Webb JG, et al Treatment of late paravalvular regurgitation after transcatheter aortic valve
implantation: prognostic implications.
Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093. PubMedAbstract available
CREA F Spotlight on aortic stenosis and dissection: mechanisms, management, and new
therapeutic targets.
Eur Heart J. 2023;44:783-787. PubMed
RODES-CABAU J, Nuche J Are contemporary TAVI results influenced by hospital volume?
Eur Heart J. 2023;44:868-870. PubMed
CHEN J, Yang Y, Wei L One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge
repair for aortic and mitral regurgitation.
Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093. PubMed
KEMALOGLU OZ T, Badano LP Can three-dimensional echocardiography change the game for the pulmonary valve?
Eur Heart J. 2023;44:703-705. PubMed
October 2021
ELLIOTT P Sudden cardiac death in hypertrophic cardiomyopathy: time to change the
narrative.
Eur Heart J. 2021;42:3945-3947. PubMed